| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs4150581 | 3-(4-hydroxyphenyl)lactate / alpha-hydroxyisovalerate | A/G | 7190 | 0.45 | -0.043 (0.003) | 2.47·10-37 | show |
| rs2403254 | alpha-hydroxyisovalerate | T/C | 7222 | 0.55 | -0.041 (0.004) | 1.26·10-30 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs4150581 |
| Chromosomal location | Chr11: 18,313,846 (11p15.1) |
| Gene (distance) | HPS5 (13,525) |
| Predicted causal gene | unknown |
| Gene/protein classification | - |
| Metabolite (Pathway) | 3-(4-hydroxyphenyl)lactate (Phenylalanine & tyrosine metabolism; Amino acid) alpha-hydroxyisovalerate (Valine, leucine and isoleucine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | Alpha-hydroxyisovalerate may be related to certain branched chain amino acid degradation metabolites. Ratio interpretation: n/a. |
| eQTL associations | - |
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | alpha-hydroxyisovalerate [21886157] |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | - |
| Drug information | - |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








